Christopher D. Hart
Prato, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: July 06, 2017
Quality indicators in breast cancer care: An update from the EUSOMA working group.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 16, 2017
Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 06, 2016
Metabolomics in Breast Cancer: Current Status and Perspectives.
Journal: Advances in experimental medicine and biology
Published: March 19, 2016
Relative benefits of newer adjuvant chemotherapy regimens in luminal breast cancer subtypes.
Journal: Breast (Edinburgh, Scotland)
Published: January 29, 2016
Using CTCs for pharmacogenomic analysis.
Journal: Pharmacological research
Published: January 07, 2016
Defining optimal duration and predicting benefit from chemotherapy in patients with luminal-like subtypes.
Journal: Breast (Edinburgh, Scotland)
Published: September 01, 2015
Challenges in the management of advanced, ER-positive, HER2-negative breast cancer.
Journal: Nature reviews. Clinical oncology
Published: May 27, 2015
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers.
Journal: BMC medicine
Published: November 26, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026